Although paclitaxel can suppress the EGFR signaling pathways in different cancer cells most probably via matrix metalloproteinases [85,86,87,88], a direct suppression of EGF receptors, in our knowledge, was not previously reported. This evidence concerns the gene EGFR and cancer.